$340.50+11.45% · 3M
Moving avg
1W+0.43%
1M+7.60%
3M+11.00%
6M-6.98%
YTD-2.21%
1Y-10.04%
3Y+19.56%
5Y+28.47%
52-week range
$281.0048% of range$404.14
Company health
Value0/6
Growth5/6
Profitability5/6
Health4/6
Dividend5/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (1510%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$130.53B
Enterprise value
$138.96B
P/E ratio (TTM)
37.83x
P/S ratio (TTM)
5.01x
EV/EBITDA
22.55x
Per share & returns
EPS (TTM)
$8.72
Dividend yield
1.05%
Beta (1Y)
0.78
30-day change
+7.60%
Trading
Volume (24h)
666.67K
Previous close
$347.21
Shares outstanding
383.36M
About Stryker Corporation
Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE
Symbol
SYK
Stryker Corporation is a large-cap healthcare company in the Medical - Devices industry. Its shares are listed on NYSE (United States) and trade under the ticker SYK.
Frequently asked questions
What is Stryker Corporation's market cap?
Stryker Corporation (SYK) has a market capitalization of $130.53B.
What is Stryker Corporation's P/E ratio?
Stryker Corporation trades at a price-to-earnings (P/E) ratio of 37.83.
What exchange does SYK trade on?
SYK trades on NYSE.
Appears in
Compare & explore
Eli Lilly and CompanyLLY
$1,217.61-0.22%
$1.15T cap
Johnson & JohnsonJNJ
$261.48+0.24%
$630.14B cap
AbbVie Inc.ABBV
$250.93+0.87%
$443.33B cap
UnitedHealth Group IncorporatedUNH
$402.36-0.80%
$365.40B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.62+1.28%
$332.49B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap